Muhamed Baljević, MD, FACP
@mmbaljevicmd
Associate Professor, Director, Plasma Cell Disorders Research and Vanderbilt Amyloidosis (VAMP) Programs. Disease Team Lead, Plasma Cell Dyscrasias & Lymphomas
ID: 766289044124930048
18-08-2016 15:01:59
676 Tweet
464 Followers
135 Following
Join me and 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 as we host this wonderful line up of 🤩speakers to discuss updates in #cancer in #Nashville Sat 6/22/24. Summary - MLS Nashville (cvent.com). CODE: MLS100 #cancerresearch @VUMC_Cancer Dr. jordan berlin Christine Lovly, MD, PhD, FASCO Oncology Brothers Matthew Villaume
#DAVAHeme and now Muhamed Baljević, MD, FACP discussing innovative bsAb combo trial in R/R high-risk #MMsm that also addresses question of recycling CD38 mAbs - coming to an ECOG center to you! For pts with >1 yr since last CD38, can dara + Tec outperform DKd or DPd? We will find out!
Living it up and chatting about all things myeloma at #DAVAHeme with Rahul Banerjee, MD, FACP Muhamed Baljević, MD, FACP Jonathan Kaufman, MD Peter Forsberg MD and Drs Ye, Hansen, Shain, and Joseph. DAVA Oncology #mmsm
#DAVAHeme a powerful call by Muhamed Baljević, MD, FACP to both study and start using better VTE PPx strategies in our patients with #MMsm. Just because aspirin is easy doesn’t make it the right answer for all!
DAVAHeme Bermuda 2024 - Rahul Banerjee, MD, FACP Timothy Schmidt, MD Meghan Thompson drjoannarhodes Peter Forsberg MD Jonathan Kaufman, MD Hearn Jay Cho MD, PhD Brittany Knick Ragon, MD Muhamed Baljević, MD, FACP Pallawi Torka Nisha Joseph, MD Nitin Jain Krish Patel Naveen Pemmaraju, MD DAVA Oncology #Cancer #OncoDaily #Oncology oncodaily.com/url/122095.html
Incredible experience at the ASH #AdvocacyLeadershipInstitute and a privilege to be able to advocate at the Capitol Hill for the #FY2025_NIH_funding #CDC_SCD_Data_Collection_Program and #SCD_Comprehensive_Care_Act(H.R.7432/S. 5097) @VUMC_Cancer Vanderbilt Health Vanderbilt Health
Lead by an amazing advocate specialists Suzanne Leous, MPA & Dr. Holter-Chakrabarty from University of Oklahoma University of Oklahoma Research, Ugochi Ogu, Quinto Gesiotto and I learned how to advocate on the biggest stage - thank you ASH for exceptional education and experience! #ASHLI @VUMC_Cancer Vanderbilt Health
I’m thrilled to announce that I’ll be chairing a session at the 2024 Summit on Hematological Cancers on October 11th - 13th! I hope you’ll join me for this exciting event in beautiful Nashville, TN!Register here: education.binayfoundation.org/content/2024-s…" @VUMC_Cancer Vanderbilt Health @VUMCHemOnc
Experts in multiple myeloma discussed optimal dosing strategies for bispecific antibodies for patients with relapsed/refractory multiple myeloma. #mmsm | Joseph Mikhael Muhamed Baljević, MD, FACP C. Ola Landgren, M.D. Cesar Rodriguez, MD (Myelomatips.com) Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Joshua Richter, MD, FACP Natalie Callander cancernetwork.com/view/determini…
Join Muhamed Baljević, MD, FACP from Vanderbilt University Medical Center, co-chair of #HemeNash25 at Nashville, TN on May 3.Reserve your spot TODAY: education.binayfoundation.org/content/case-b…… #MedEd #HemOnc #Medtwitter #MedX #Oncology
Join Dr. Christopher D'Angelo from Nebraska Medicine and Muhamed Baljević, MD, FACP from @VUMC_Cancer in the fight against blood cancer during #MultipleMyeloma Awareness Month! Register for our CME/MOC-accredited events: buff.ly/eadT3C0 Learn more: buff.ly/7Bsq9dH #MyelomaMilestone
📢NEW #SpecialIssue ON "#Immune Landscape of #Multiple #Myeloma" 🔗 mdpi.com/journal/cancer… 👨⚕️Guest Editors: Dr. Muhamed Baljevic Muhamed Baljević, MD, FACP and Dr. Shebli Atrash Shebli Atrash 🗓️Submission Deadline: 31 March 2026
